Jove
Visualize
Contact Us

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The function of ultra-large von Willebrand factor multimers in high shear flow controlled by ADAMTS13.

Hamostaseologie·2015
Same author

The EPIC study: a lesson to learn.

Haemophilia : the official journal of the World Federation of Hemophilia·2015
Same author

Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis--new insight provided by pharmacokinetic modelling.

Haemophilia : the official journal of the World Federation of Hemophilia·2015
Same author

Flow-dependent thrombin and fibrin generation in vitro: opportunities for standardization: communication from SSC of the ISTH.

Journal of thrombosis and haemostasis : JTH·2013
Same author

The principles of PK-tailored prophylaxis.

Hamostaseologie·2013
Same author

Development of novel treatment options for patients with haemophilia.

Hamostaseologie·2013
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 26, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Platelet function under high shear conditions.

A J Reininger1

  • 1University Clinic Munich, Department of Transfusion Medicine, Max-Lebsche-Platz 32, 81377 Munich, Germany. Armin.Reininger@med.uni-muenchen.de

Hamostaseologie
|January 20, 2009
PubMed
Summary

Platelets prevent bleeding by forming clots, especially under high shear stress. Von Willebrand factor (VWF) is crucial for initial platelet adhesion and building the clot at injury sites.

Area of Science:

  • Hematology
  • Biophysics
  • Cell Biology

Background:

  • Blood platelets are essential for hemostasis, preventing blood loss from damaged blood vessels.
  • Under high shear conditions, platelet function is critical for forming a stable hemostatic plug while avoiding thrombosis.

Purpose of the Study:

  • To elucidate the mechanisms of platelet adhesion and aggregation under high shear flow.
  • To understand the role of von Willebrand factor (VWF) in mediating platelet function in vascular injury.

Main Methods:

  • Investigated platelet-surface interactions under simulated high shear flow conditions.
  • Examined the binding of platelet receptors to immobilized von Willebrand factor (VWF) and collagen.

Main Results:

More Related Videos

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Related Experiment Videos

Last Updated: Jun 26, 2026

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

  • Platelet receptors like integrin alpha2bbeta1 and GPVI are insufficient for high shear arrest.
  • The GPIbalpha-VWF interaction is essential for initial platelet adhesion to the subendothelium at high shear rates.
  • VWF mediates subsequent platelet aggregation, forming a multilayered hemostatic plug.

Conclusions:

  • Von Willebrand factor (VWF) is indispensable for platelet function and hemostasis under high shear stress.
  • Targeting the GPIbalpha-VWF interaction could be a strategy for managing bleeding disorders or thrombotic events.